Table 3.

Patients Experiencing Adverse Events.

Adverse Event	Lithium (n=38)	Placebo (n=39)	P value*
Increased agitation	6 (15.8%)	11 (28.2%)	0.27
Fall	7 (18.4%)	3 (7.7%)	0.19
Diarrhea	3 (7.9%)	4 (10.3%)	1.0
Reduced Kidney Function	3 (7.9%)	2 (5.1%)	0.68
Vomiting	4 (10.5%)	1 (2.6%)	0.2
Gait instability	4 (10.5%)	0 (0%)	0.055
UTI	2 (5.3%)	2 (5.1%)	1.0
Insomnia	2 (5.3%)	1 (2.6%)	0.62
Pneumonia	2 (5.3%)	1 (2.6%)	0.62
Tremor	3 (7.9%)	0 (0%)	0.12
Abdominal pain	2 (5.3%)	0 (0%)	0.24
Contact dermatitis	1 (2.6%)	1 (2.6%)	1.0
Headache	1 (2.6%)	1 (2.6%)	1.0
Increased anxiety	2 (5.3%)	0 (0%)	0.24
Increased confusion	1 (2.6%)	1 (2.6%)	1.0
Muscle pain	0 (0%)	2 (5.1%)	0.49
Myoclonus	1 (2.6%)	1 (2.6%)	1.0
URI	0 (0%)	2 (5.1%)	0.49

Adverse events that occurred in at least two patients in the entire sample are listed.

^*Fisher’s exact test was used.